Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + phenylephrine is a combination topical solution used primarily in nasal and pharyngeal procedures. **Lidocaine**, a local anesthetic of the amide class, blocks sodium channels in nerve membranes to inhibit nerve impulse generation and conduction, producing numbness. **Phenylephrine**, an alpha-1 adrenergic receptor agonist sympathomimetic, induces vasoconstriction to reduce bleeding. The formulation (typically 5% lidocaine HCl and 0.5% phenylephrine HCl) is applied as a spray for preparation of nasal mucosa for surgery or endoscopy, aid in foreign body removal from the nose, and pharyngeal analgesia prior to laryngoscopy.[1][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + phenylephrine.